Go Pro
→ The window is closing (From American Alternative) (Ad)tc pixel Free UPHL Stock Alerts

UpHealth (UPHL) Competitors

$0.0001 0.00 (-66.67%)
As of 09:32 AM Eastern
Compare

UPHL vs. BTTX, ACONW, DHACW, LFMDP, and PIIIW

Should you buy UpHealth stock or one of its competitors? MarketBeat compares UpHealth with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with UpHealth include Better Therapeutics (BTTX), Aclarion (ACONW), Digital Health Acquisition (DHACW), LifeMD (LFMDP), and P3 Health Partners (PIIIW). These companies are all part of the "healthcare" industry.

How does UpHealth compare to Better Therapeutics?

Better Therapeutics (NASDAQ:BTTX) and UpHealth (NYSE:UPHL) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, media sentiment, earnings, institutional ownership, risk, profitability and valuation.

Better Therapeutics has a beta of 0.87, suggesting that its share price is 13% less volatile than the broader market. Comparatively, UpHealth has a beta of 0.5, suggesting that its share price is 50% less volatile than the broader market.

Better Therapeutics has higher earnings, but lower revenue than UpHealth. Better Therapeutics is trading at a lower price-to-earnings ratio than UpHealth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Better TherapeuticsN/AN/A-$39.76M-$0.39N/A
UpHealth$130M0.00-$56.42M$1.980.00

Company Net Margins Return on Equity Return on Assets
Better TherapeuticsN/A N/A N/A
UpHealth N/A N/A N/A

In the previous week, Better Therapeutics' average media sentiment score of 0.00 equaled UpHealth'saverage media sentiment score.

Company Overall Sentiment
Better Therapeutics Neutral
UpHealth Neutral

34.0% of Better Therapeutics shares are owned by institutional investors. Comparatively, 56.1% of UpHealth shares are owned by institutional investors. 51.4% of Better Therapeutics shares are owned by insiders. Comparatively, 34.2% of UpHealth shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

UpHealth beats Better Therapeutics on 4 of the 7 factors compared between the two stocks.

How does UpHealth compare to Aclarion?

Aclarion (NASDAQ:ACONW) and UpHealth (NYSE:UPHL) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, media sentiment, dividends, risk, profitability, valuation and earnings.

56.1% of UpHealth shares are owned by institutional investors. 34.2% of UpHealth shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Aclarion has higher earnings, but lower revenue than UpHealth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aclarion$77.88KN/AN/AN/AN/A
UpHealth$130M0.00-$56.42M$1.980.00

In the previous week, Aclarion's average media sentiment score of 0.00 equaled UpHealth'saverage media sentiment score.

Company Overall Sentiment
Aclarion Neutral
UpHealth Neutral

Company Net Margins Return on Equity Return on Assets
AclarionN/A N/A N/A
UpHealth N/A N/A N/A

Summary

UpHealth beats Aclarion on 3 of the 3 factors compared between the two stocks.

How does UpHealth compare to Digital Health Acquisition?

Digital Health Acquisition (NASDAQ:DHACW) and UpHealth (NYSE:UPHL) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their risk, profitability, earnings, institutional ownership, analyst recommendations, valuation, dividends and media sentiment.

Digital Health Acquisition has higher earnings, but lower revenue than UpHealth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Digital Health AcquisitionN/AN/AN/AN/AN/A
UpHealth$130M0.00-$56.42M$1.980.00

In the previous week, Digital Health Acquisition's average media sentiment score of 0.00 equaled UpHealth'saverage media sentiment score.

Company Overall Sentiment
Digital Health Acquisition Neutral
UpHealth Neutral

56.1% of UpHealth shares are owned by institutional investors. 34.2% of UpHealth shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
Digital Health AcquisitionN/A N/A N/A
UpHealth N/A N/A N/A

Summary

UpHealth beats Digital Health Acquisition on 3 of the 3 factors compared between the two stocks.

How does UpHealth compare to LifeMD?

UpHealth (NYSE:UPHL) and LifeMD (NASDAQ:LFMDP) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings and profitability.

In the previous week, UpHealth's average media sentiment score of 0.00 equaled LifeMD'saverage media sentiment score.

Company Overall Sentiment
UpHealth Neutral
LifeMD Neutral

56.1% of UpHealth shares are owned by institutional investors. 34.2% of UpHealth shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

LifeMD has higher revenue and earnings than UpHealth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
UpHealth$130M0.00-$56.42M$1.980.00
LifeMD$193.33MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
UpHealthN/A N/A N/A
LifeMD N/A N/A N/A

Summary

UpHealth beats LifeMD on 2 of the 3 factors compared between the two stocks.

How does UpHealth compare to P3 Health Partners?

UpHealth (NYSE:UPHL) and P3 Health Partners (NASDAQ:PIIIW) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, dividends, valuation, profitability, media sentiment and analyst recommendations.

In the previous week, UpHealth's average media sentiment score of 0.00 equaled P3 Health Partners'average media sentiment score.

Company Overall Sentiment
UpHealth Neutral
P3 Health Partners Neutral

P3 Health Partners has higher revenue and earnings than UpHealth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
UpHealth$130M0.00-$56.42M$1.980.00
P3 Health Partners$1.47BN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
UpHealthN/A N/A N/A
P3 Health Partners N/A N/A N/A

56.1% of UpHealth shares are owned by institutional investors. 34.2% of UpHealth shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

UpHealth beats P3 Health Partners on 2 of the 3 factors compared between the two stocks.

Get UpHealth News Delivered to You Automatically

Sign up to receive the latest news and ratings for UPHL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UPHL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

UPHL vs. The Competition

Export
MetricUpHealthHealth services IndustryMedical SectorNYSE Exchange
Market Cap$2K$1.37M$6.87B$23.46B
Dividend YieldN/AN/A2.67%4.01%
P/E Ratio0.00N/A27.3731.25
Price / Sales0.000.00497.5184.60
Price / CashN/AN/A49.2425.14
Price / Book0.000.0011.094.78
Net Income-$56.42M-$56.42M$3.57B$1.07B
7 Day PerformanceN/AN/A0.08%-0.53%
1 Month PerformanceN/AN/A5.37%1.43%
1 Year PerformanceN/AN/A30.73%16.62%

UpHealth Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
UPHL
UpHealth
N/A$0.00
-66.7%		N/A+50.0%$2K$130MN/A1,750
BTTX
Better Therapeutics
N/AN/AN/A+0.0%$4KN/AN/A40
ACONW
Aclarion
N/A$0.03
flat		N/A-26.4%$0.00$77.88KN/A7
DHACW
Digital Health Acquisition
N/A$0.04
flat		N/AN/A$0.00N/AN/AN/A
LFMDP
LifeMD
N/A$23.37
-0.4%		N/A-0.2%$0.00$193.33MN/A230

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NYSE:UPHL) was last updated on 7/9/2026 by MarketBeat.com Staff.
From Our Partners
The window is closing
We printed 1,000 copies of this report and 688 are gone—when the last one goes out, we're pulling it offline b...
American Alternative | Sponsoredtc pixel
Better than SpaceX? Grab this ticker instead.
Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...
Brownstone Research | Sponsoredtc pixel
The sell discipline that changed my mind after 30 years
Porter Stansberry spent 30 years ignoring outside investment systems - until he met Emmet Savage in Dublin. Sa...
Porter & Company | Sponsoredtc pixel